Skip to content
2000
Volume 31, Issue 12
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Background

PGK1 and PKM2 are glycolytic enzymes, and their expression is upregulated in cancer cells. STAT3 is a transcription factor implicated in breast cancer progression and chemoresistance. Researchers worldwide continue to explore how targeting genes might lead to more effective anti-breast cancer therapies. The present study aims to synthesize quinazolines containing caffeoyl moiety for developing innovative anticancer agents against the human breast cancer cell line (MCF-7).

Methods

A new quinazoline was synthesized by reacting caffeic acid with 5-amino-phenylpyrazole carboxylate in the presence of PCl. Compound reacted with NHNH.HO to produce compound through cyclo-condensation. Apoptosis and necrosis as well as inhibition activity compounds and against PGK1, and PKM2 were evaluated. The effect of compounds and on the levels of GSH, GR, SOD, GPx, CAT, MDA, Bax, Bcl-2, caspase-3, P53 and VEGF levels as well as PGK1, PKM2 and STAT3 gene expression were estimated in MCF-7 tumor cells.

Results

The viability of MCF-7 cells was reduced to 22.42% and 45.86% after incubation with compounds and for 48 hours, respectively. The IC values for compounds and are 62.05 µg/mL and 16.73 µg/mL. Furthermore, compound exhibited more significant apoptosis and necrosis than compound . IC values of compound against PGK1, and PKM2 at interval concentration equals 1.04, and 0.32 µM/mL, respectively, after 210 minutes of incubation. Moreover, compound were revealed strong inhibition of PGK1, and PKM2 with IC values equals 0.55 and 0.21 µg/mL, respectively after 210 minutes of incubation. Our results proved that the incubation of compounds and with MCF-7 cells increased the levels of apoptotic proteins, elevated MDA, Bax, caspase-3 and P53 levels, depleted GSH, GR, SOD, GPx, CAT, Bcl-2 levels and down-regulated the levels of STAT3, PGK1, and PKM2 gene expression significantly. Our results proved that compound showed a stronger estimated binding affinity with a ∆G of -7.2, -7.5, and -7.9 kcal/mol., respectively towards PGK1, PKM2 and STAT3 proteins. Also, compound exhibits a strong binding affinity with ∆G of -7.9, -8.5, and - 8.7 kcal/mol., towards PGK1, PKM2 and STAT3 proteins.

Conclusion

The results show that compounds and induce apoptotic activity by blocking the PGK1-PKM2-STAT3 signaling pathway. The present investigation opens exciting possibilities for developing innovative new anticancer quinazolines bearing caffeoyl moiety.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128337881241016064641
2024-11-05
2025-03-29
Loading full text...

Full text loading...

References

  1. ZhangX. WangJ. ZhuangJ. A novel glycolysis-related four-mRNA signature for predicting the survival of patients with breast cancer.Front. Genet.20211260693710.3389/fgene.2021.606937 33584825
    [Google Scholar]
  2. SungH. FerlayJ. SiegelR.L. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202171320924910.3322/caac.21660 33538338
    [Google Scholar]
  3. ZocchiM HechtCMF AlimohammadiF Abstract 449: Catabolism of GSH by GGT supports cancer cell survival.Cancer Res2024846_Supplement)(Suppl.44910.1158/1538‑7445.AM2024‑449
    [Google Scholar]
  4. TekinS. SevenE. Assessment of serum catalase, reduced glutathione, and superoxide dismutase activities and malondialdehyde levels in keratoconus patients.Eye (Lond.)202236102062206610.1038/s41433‑021‑01753‑1 34462580
    [Google Scholar]
  5. AhmadS.S. GlatzleJ. BajaeiferK. BühlerS. LehmannT. KönigsrainerI. Phosphoglycerate kinase 1 as a promoter of metastasis in colon cancer.Int. J. Oncol.201343258659010.3892/ijo.2013.1971
    [Google Scholar]
  6. TekadeR.K. SunX. The Warburg effect and glucose-derived cancer theranostics.Drug Discov. Today201722111637165310.1016/j.drudis.2017.08.003 28843632
    [Google Scholar]
  7. LiY. WangS. ZhangX. Expression characteristics and significant prognostic values of PGK1 in breast cancer.Front. Mol. Biosci.2021869542010.3389/fmolb.2021.695420 34291087
    [Google Scholar]
  8. MazurekS. Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells.Int. J. Biochem. Cell Biol.201143796998010.1016/j.biocel.2010.02.005 20156581
    [Google Scholar]
  9. GuptaV. BamezaiR.N.K. Human pyruvate kinase M2: A multifunctional protein.Protein Sci.201019112031204410.1002/pro.505 20857498
    [Google Scholar]
  10. LinY. LvF. LiuF. High expression of pyruvate kinase M2 is associated with chemosensitivity to epirubicin and 5-fluorouracil in breast cancer.J. Cancer20156111130113910.7150/jca.12719 26516361
    [Google Scholar]
  11. HuY. DongZ. LiuK. Unraveling the complexity of STAT3 in cancer: Molecular understanding and drug discovery.J. Exp. Clin. Cancer Res.20244312310.1186/s13046‑024‑02949‑5 38245798
    [Google Scholar]
  12. FaragA.M. AliK.A.K. El-DebssT.M.A. Design, synthesis and structure–activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents.Eur. J. Med. Chem.201045125887589810.1016/j.ejmech.2010.09.054 20950898
    [Google Scholar]
  13. GomhaS.M. HassaneenH.M.E. Synthesis and antimicrobial activity of some new pyrazoles, fused pyrazolo[3,4-d]-pyrimidine and 1,2-dihydroimidazo-[2,1-c][1,2,4]triazin-6-one derivatives.Molecules20111686549656010.3390/molecules16086549 21818058
    [Google Scholar]
  14. HusseinM.A. BorikR.M. NafieM.S. Abo-SalemH.M. BoshraS.A. MohamedZ.N. Structure activity relationship and molecular docking of some quinazolines bearing sulfamerazine moiety as new 3CLpro, cPLA2, sPLA2 inhibitors.Molecules20232816605210.3390/molecules28166052 37630304
    [Google Scholar]
  15. HusseinM.A. Synthesis of some novel triazoloquinazolines and triazinoquinazolines and their evaluation for anti-inflammatory activity.Med. Chem. Res.2010818761886
    [Google Scholar]
  16. BorikR.M. HusseinM.A. Synthesis, molecular docking, biological potentials and structure-activity relationship of new quinazoline and quinazoline-4-one derivatives.Asian J. Chem.202133242343810.14233/ajchem.2021.23036
    [Google Scholar]
  17. HusseinM.A. BorikR.M. A novel quinazoline-4-one derivatives as a promising cytokine inhibitors: Synthesis, molecular docking, and structure-activity relationship.Curr. Pharm. Biotechnol.20222391179120310.2174/1389201022666210601170650 34077343
    [Google Scholar]
  18. El GizawyH.A. Abo-SalemH.M. AliA.A. HusseinM.A. Phenolic profiling and therapeutic potential of certain isolated compounds from Parkia roxburghii against AChE activity as well as GABAA α5, GSK-3β, and p38α MAP-kinase genes.ACS Omega2021631204922051110.1021/acsomega.1c02340 34395996
    [Google Scholar]
  19. MohamadE.A. MohamedZ.N. HusseinM.A. ElneklawiM.S. GANE can improve lung fibrosis by reducing inflammation via promoting p38MAPK/TGF-β1/NF-κB signaling pathway downregulation.ACS Omega2022733109312010.1021/acsomega.1c06591 35097306
    [Google Scholar]
  20. M Soliman S, Mosallam S, Mamdouh MA, Hussein MA, M Abd El-Halim S. Design and optimization of cranberry extract loaded bile salt augmented liposomes for targeting of MCP-1/STAT3/] VEGF signaling pathway in DMN-intoxicated liver in rats.Drug Deliv.202229142743910.1080/10717544.2022.2032875 35098843
    [Google Scholar]
  21. MostafaM.M. AminM.M. ZakariaM.Y. HusseinM.A. ShamaaM.M. Abd El-HalimS.M. Chitosan surface-modified PLGA nanoparticles loaded with cranberry powder extract as a potential oral delivery platform for targeting colon cancer cells.Pharmaceutics202315260610.3390/pharmaceutics15020606 36839928
    [Google Scholar]
  22. BoshraS.A. HusseinM.A. Cranberry extract as a supplemented food in the treatment of oxidative stress and breast cancer induced by N-Methyl-N-Nitrosourea in female virgin rats.Int. J. Phytomed.20168217227
    [Google Scholar]
  23. EldourghamyA. HossamT. HusseinM.A. Abdel-AzizA. El-masryS.A. Naringenin suppresses NLRP3 inflammasome activation via the mRNA-208a signaling pathway in isoproterenol-induced myocardial infarction.Asian Pac. J. Trop. Biomed.2023131044345010.4103/2221‑1691.387750
    [Google Scholar]
  24. GomhaS.M. AbdallahM.A. AbbasI.M. KazemM.S.H. Synthesis, cytotoxicity evaluation, molecular docking and utility of novel chalcones as precursors for heterocycles incorporating pyrazole moiety.Med. Chem.201814434435510.2174/1573406413666171020114105 29065841
    [Google Scholar]
  25. AbbasI.M. AbdallahM.A. GomhaS.M. KazemM.S.H. Synthesis and antimicrobial activity of novel azolopyrimidines and pyrido‐triazolo‐pyrimidinones incorporating pyrazole moiety.J. Heterocycl. Chem.20175463447345710.1002/jhet.2968
    [Google Scholar]
  26. GomhaS.M. DawoodK.M. Synthetic utility of pyridinium bromide: Synthesis and antimicrobial activity of novel 2,4,6‐trisubstituted pyridines having pyrazole moiety.J. Heterocycl. Chem.20175431943194810.1002/jhet.2790
    [Google Scholar]
  27. MineY. Egg proteins and peptides in human health-chemistry, bioactivity and production.Curr. Pharm. Des.200713987588410.2174/138161207780414278 17430187
    [Google Scholar]
  28. ChenC.Y. KaoC.L. LiuC.M. The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway.Int. J. Mol. Sci.2018199272910.3390/ijms19092729 30213077
    [Google Scholar]
  29. ChungT.W. MoonS.K. ChangY.C. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: Complete regression of hepatoma growth and metastasis by dual mechanism.FASEB J.200418141670168110.1096/fj.04‑2126com 15522912
    [Google Scholar]
  30. SulD. KimH.S. LeeD. JooS.S. HwangK.W. ParkS.Y. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation.Life Sci.2009849-1025726210.1016/j.lfs.2008.12.001 19101570
    [Google Scholar]
  31. JungJ.E. KimH.S. LeeC.S. Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells.Carcinogenesis20072881780178710.1093/carcin/bgm130 17557905
    [Google Scholar]
  32. KangN.J. LeeK.W. KimB.H. Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK.Carcinogenesis201132692192810.1093/carcin/bgr022 21317303
    [Google Scholar]
  33. Abdel-GawadS.M. GhorabM.M. El-ShariefA.M.S. El-TelbanyF.A. Abdel-AllaM. Design, synthesis, and antimicrobial activity of some new pyrazolo[3,4‐d]pyrimidines.Heteroatom Chem.200314653053410.1002/hc.10187
    [Google Scholar]
  34. SayedA.R. GomhaS.M. AbdelrazekF.M. FarghalyM.S. HassanS.A. MetzP. Design, efficient synthesis and molecular docking of some novel thiazolyl-pyrazole derivatives as anticancer agents.BMC Chem.201913111610.1186/s13065‑019‑0632‑5 31572983
    [Google Scholar]
  35. GomhaS.M. Abdel-azizH.M. BadreyM.G. AbdullaM.M. Efficient synthesis of some new 1,3,4‐thiadiazoles and 1,2,4‐triazoles linked to pyrazolylcoumarin ring system as potent 5α‐reductase inhibitors.J. Heterocycl. Chem.20195641275128210.1002/jhet.3487
    [Google Scholar]
  36. AbdelhamidA.O. GomhaS.M. El-EnanyW.A.M.A. Efficient synthesis and antimicrobial evaluation of new azolopyrimidines‐bearing pyrazole moiety.J. Heterocycl. Chem.20195692487249310.1002/jhet.3638
    [Google Scholar]
  37. EdreesM.M. MelhaS.A. SaadA.M. KhederN.A. GomhaS.M. MuhammadZ.A. Eco-friendly synthesis, characterization and biological evaluation of some novel pyrazolines containing thiazole moiety as potential anticancer and antimicrobial agents.Molecules20182311297010.3390/molecules23112970 30441815
    [Google Scholar]
  38. TampaM. NicolaeI. EneC.D. SarbuI. MateiC. GeorgescuS.R. Vitamin C, and tbars in psoriasis vulgaris related to psoriasis area severity index (PASI).Revista de Chimie201768434710.37358/RC.17.1.5385
    [Google Scholar]
  39. NishikimiM. AppajiN. YagiK. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen.Biochem. Biophys. Res. Commun.197246284985410.1016/S0006‑291X(72)80218‑3
    [Google Scholar]
  40. AebiH. Catalase in vitro.Methods Enzymol198410512112610.1016/S0076‑6879(84)05016‑3 6727660
    [Google Scholar]
  41. MaiorinoF.M. Brigelius-FlohéR. AumannK.D. Diversity of glutathione peroxidases.Methods Enzymol1995252385310.1016/0076‑6879(95)52007‑4 7476373
    [Google Scholar]
  42. DymO. EisenbergD. Sequence‐structure analysis of FAD‐containing proteins.Protein Sci.20011091712172810.1110/ps.12801 11514662
    [Google Scholar]
  43. MorrisG.M. HueyR. LindstromW. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.J. Comput. Chem.200930162785279110.1002/jcc.21256 19399780
    [Google Scholar]
  44. JiménezJ. DoerrS. Martínez-RosellG. RoseA.S. De FabritiisG. DeepSite: Protein-binding site predictor using 3D-convolutional neural networks.Bioinformatics201733193036304210.1093/bioinformatics/btx350 28575181
    [Google Scholar]
  45. DongJ. WangN.N. YaoZ.J. ADMETlab: A platform for systematic ADMET evaluation based on a comprehensively collected ADMET database.J. Cheminform.20181012910.1186/s13321‑018‑0283‑x 29943074
    [Google Scholar]
  46. ElgizawyH.A. AliA.A. Resveratrol: Isolation, and its nanostructured lipid carriers, inhibits cell proliferation, induces cell apoptosis in certain human cell lines carcinoma and exerts protective against paraquat-induced hepatotoxicity.J. Med. Food20212418910010.1089/jmf.2019.0286 32580673
    [Google Scholar]
  47. HusseinM.A. El-GizawyH.A.E. Synthesis of cinnamyl and caffeoyl derivatives of cucurbitacin-e-glycoside isolated from citrullus colocynthis fruits and their structures antioxidant and anti-inflammatory.Curr. Pharm. Biotechnol.201718867769310.2174/1389201018666171004144615 28982326
    [Google Scholar]
  48. MillerK.D. SiegelR.L. LinC.C. Cancer treatment and survivorship statistics, 2016.CA Cancer J. Clin.201666427128910.3322/caac.21349 27253694
    [Google Scholar]
  49. NadileM. RetsidouM.I. GiotiK. BeloukasA. TsianiE. Resveratrol against cervical cancer: Evidence from in vitro and in vivo studies.Nutrients20221424527310.3390/nu14245273
    [Google Scholar]
  50. KeerthanaC.K. RayginiaT.P. ShifanaS.C. The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment.Front. Immunol.202314111458210.3389/fimmu.2023.1114582 36875093
    [Google Scholar]
  51. GülçinI. Antioxidant activity of caffeic acid (3,4-dihydroxy-cinnamic acid).Toxicology20062172-321322010.1016/j.tox.2005.09.011 16243424
    [Google Scholar]
  52. RanF. LiuY. LiuM. Discovery of pyrazolopyrimidine derivatives as potent BTK inhibitors with effective anticancer activity in MCL.Bioorg. Chem.20198910294310.1016/j.bioorg.2019.102943 31031018
    [Google Scholar]
  53. BaillacheD.J. Unciti-BrocetaA. Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold.RSC Med. Chem.202011101112113510.1039/D0MD00227E 33479617
    [Google Scholar]
  54. RosendahlA.H. PerksC.M. ZengL. Caffeine and caffeic acid inhibit growth and modify estrogen receptor and insulin-like growth factor i receptor levels in human breast cancer.Clin. Cancer Res.201521818771887
    [Google Scholar]
  55. SandersonJ.T. ClabaultH. PattonC. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.Bioorg. Med. Chem.201321227182719310.1016/j.bmc.2013.08.057 24080105
    [Google Scholar]
  56. ChiangE.P.I. TsaiS.Y. KuoY.H. Caffeic acid derivatives inhibit the growth of colon cancer: Involvement of the PI3-K/Akt and AMPK signaling pathways.PLoS One201496e9963110.1371/journal.pone.0099631 24960186
    [Google Scholar]
  57. GuoD. DouD. GeL. HuangZ. WangL. GuN. A caffeic acid mediated facile synthesis of silver nanoparticles with powerful] anti-cancer activity.Colloids Surf. B Biointerfaces201513422923410.1016/j.colsurfb.2015.06.070 26208293
    [Google Scholar]
  58. AkinleyeA. ChenY. MukhiN. SongY. LiuD. Ibrutinib and novel BTK inhibitors in clinical development.J. Hematol. Oncol.2013615910.1186/1756‑8722‑6‑59 23958373
    [Google Scholar]
  59. AntonelloA. TarozziA. MorroniF. Multitarget-directed drug design strategy: A novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects.J. Med. Chem.200649236642664510.1021/jm0608762 17154492
    [Google Scholar]
  60. BrownM. CheungM. DickersonS. Pyrazolopyrimidines as protein kinase inhibitors.US Patent 7449488B22008
    [Google Scholar]
  61. JiaL. HuangS. YinX. ZanY. GuoY. HanL. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.Life Sci.201820812313010.1016/j.lfs.2018.07.027 30025823
    [Google Scholar]
  62. MinH.Y. PeiH. HyunS.Y. Potent anticancer effect of the natural steroidal saponin gracillin is produced by inhibiting glycolysis and oxidative phosphorylation-mediated bioenergetics.Cancers (Basel)202012491310.3390/cancers12040913 32276500
    [Google Scholar]
  63. MohsinN.A. IrfanM. HassanS. SaleemU. Current strategies in the development of new chromone derivatives with diversified pharmacological activities: A review.Pharm. Chem. J.202054324125710.1007/s11094‑020‑02187‑x 32836513
    [Google Scholar]
  64. MansourM.S. MahmoudA.A. SayahM.A. RES-CMCNPs enhance antioxidant, proinflammatory, and sensitivity of tumor solids to γ-irradiation in EAC-bearing mice.Pharm. Nanotechnol.202410.2174/0122117385290497240324190453
    [Google Scholar]
  65. MichalaA.S. PritsaA. Quercetin: A molecule of great biochemical and clinical value and its beneficial effect on diabetes and cancer.Diseases20221033710.3390/diseases10030037 35892731
    [Google Scholar]
  66. WangT. LiQ. BiK. Bioactive flavonoids in medicinal plants: Structure, activity and biological fate.Asian J. Pharm. Sci.2018131122310.1016/j.ajps.2017.08.004 32104374
    [Google Scholar]
  67. ZhengL.F. DaiF. ZhouB. YangL. LiuZ.L. Prooxidant activity of hydroxycinnamic acids on DNA damage in the presence of Cu(II) ions: Mechanism and structure–activity relationship.Food Chem. Toxicol.200846114915610.1016/j.fct.2007.07.010 17764801
    [Google Scholar]
  68. BhosleS.M. HuilgolN.G. MishraK.P. Enhancement of radiation-induced oxidative stress and cytotoxicity in tumor cells by ellagic acid.Clin. Chim. Acta20053591-28910010.1016/j.cccn.2005.03.037 15922998
    [Google Scholar]
  69. AubreyB.J. KellyG.L. JanicA. HeroldM.J. StrasserA. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?Cell Death Differ.201825110411310.1038/cdd.2017.169 29149101
    [Google Scholar]
  70. BeyfussK. HoodD.A. A systematic review of p53 regulation of oxidative stress in skeletal muscle.Redox Rep.201823110011710.1080/13510002.2017.1416773 29298131
    [Google Scholar]
  71. HauptS. BergerM. GoldbergZ. HauptY. Apoptosis - The p53 network.J. Cell Sci.2003116204077408510.1242/jcs.00739 12972501
    [Google Scholar]
  72. AnwerK.E. El-SattarN.E.A.A. ShamaaM.M. ZakariaM.Y. BeshayB.Y. Design, green synthesis and tailoring of vitamin E tpgs augmented niosomal nano-carrier of pyrazolopyrimidines as potential anti-liver and breast cancer agents with accentuated oral bioavailability.Pharmaceuticals (Basel)202215333010.3390/ph15030330 35337128
    [Google Scholar]
  73. ZhuY. JiangY. ShiL. 7-O-Geranylquercetin induces apoptosis in gastric cancer cells via ROS-MAPK mediated mitochondrial signaling pathway activation.Biomed. Pharmacother.20178752753810.1016/j.biopha.2016.12.095 28076833
    [Google Scholar]
  74. LiuH. ZhouM. Antitumor effect of Quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways.BMC Complement. Altern. Med.201717153110.1186/s12906‑017‑2023‑6 29237430
    [Google Scholar]
  75. GarbersC SchellerJ. Interleukin-6 and interleukin-11: Same same but different.bchm201339491145116110.1515/hsz‑2013‑016623740659
    [Google Scholar]
  76. GründkerC. WokounU. HellriegelM. EmonsG. Inhibition of aerobic glycolysis enhances the anti‐tumor efficacy of Zoptarelin Doxorubicin in triple‐negative breast cancer cells.J. Obstet. Gynaecol. Res.20194571334134210.1111/jog.13980 31016845
    [Google Scholar]
  77. QianX. LiX. LuZ. Protein kinase activity of the glycolytic enzyme PGK1 regulates autophagy to promote tumorigenesis.Autophagy20171371246124710.1080/15548627.2017.1313945 28486006
    [Google Scholar]
  78. Vander HeidenM.G. ChristofkH.R. SchumanE. Identification of small molecule inhibitors of pyruvate kinase M2.Biochem. Pharmacol.20107981118112410.1016/j.bcp.2009.12.003 20005212
    [Google Scholar]
  79. AslanE. GulerC. AdemS. In vitro effects of some flavonoids and phenolic acids on human pyruvate kinase isoenzyme M2.J. Enzyme Inhib. Med. Chem.201631231431710.3109/14756366.2015.1022173 25798688
    [Google Scholar]
  80. AbolibdaT.Z. FathallaM. AljohaniG.F. ZayedE.M. GomhaS.M. Synthesis and in silico antiviral activity of novel bioactive thiobarbituric acid based hydrazones and pyrazoles against SARS-CoV-2 main protease (Mpro).Polycycl. Aromat. Compd.20234387635765010.1080/10406638.2022.2138922
    [Google Scholar]
  81. Abu-MelhaS. EdreesM.M. RiyadhS.M. AbdelazizM.R. ElfikyA.A. GomhaS.M. Clean grinding technique: A facile synthesis and in silico antiviral activity of hydrazones, pyrazoles, and pyrazines bearing thiazole moiety against SARS-CoV-2 main protease (Mpro).Molecules20202519456510.3390/molecules25194565 33036293
    [Google Scholar]
/content/journals/cpd/10.2174/0113816128337881241016064641
Loading
/content/journals/cpd/10.2174/0113816128337881241016064641
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test